Vina-ginsenoside R8
CAS No. 156042-22-7
Vina-ginsenoside R8( ——— )
Catalog No. M38679 CAS No. 156042-22-7
Vinaginsenoside R8, a triterpenoid glycoside isolated from the rhizomes of Panacis majoris. Vinaginsenoside R8 displays activities against adenosine diphosphate (ADP)-induced platelet aggregation (IC50=25.18 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 432 | Get Quote |
|
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVina-ginsenoside R8
-
NoteResearch use only, not for human use.
-
Brief DescriptionVinaginsenoside R8, a triterpenoid glycoside isolated from the rhizomes of Panacis majoris. Vinaginsenoside R8 displays activities against adenosine diphosphate (ADP)-induced platelet aggregation (IC50=25.18 μM).
-
DescriptionVinaginsenoside R8 is a natural product
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number156042-22-7
-
Formula Weight963.165
-
Molecular FormulaC48H82O19
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Min Li, et al. Studies on triterpenoid glycosides from rhizomes of Panacis majoris and their antiplatelet aggregation activity. Chemical Research in Chinese Universities.
molnova catalog
related products
-
Linaprazan glurate
Linaprazan glurate inhibits exogenously or endogenously stimulated gastric acid secretion. Linaprazan glurate can be used in studies about gastrointestinal inflammatory diseases and peptic ulcer diseases.
-
Ganglioside GM1
Ganglioside GM1 is one of the major sphingolipids (GSLs) on the cell surface of the central nervous system (CNS), which is protective of the CNS and is used in the study of neurological disorders.
-
CCG-63808
CCG-63808 is a reversible inhibitor of regulator of G-protein signaling (RGS) proteins.
Cart
sales@molnova.com